Beatrice P. Concepcion, MD is a transplant nephrologist and Associate Professor of Medicine in the Section of Nephrology. She serves as the medical director of the kidney and pancreas transplant program and Practice Chair of the Transplant Institute.
Dr. Concepcion received her medical school degree in 2004 from the University of the Philippines in Manila. She pursued further training in Internal Medicine and Nephrology at Rush University Medical Center in Chicago, IL and completed a fellowship in Transplant Nephrology at Vanderbilt University Medical Center in Nashville, TN in 2011. Prior to joining the University of Chicago in 2023, she was a faculty member at Vanderbilt for 10 years.
As medical director of the transplant program, she actively works with the multi-disciplinary team to maintain excellent patient outcomes and patient satisfaction, and to foster growth and innovation. Dr. Concepcion is a busy clinician caring for kidney transplant recipients and evaluating recipient and living donor candidates. In addition to her administrative and clinical responsibilities, she is actively involved in the education of transplant nephrology and general nephrology fellows and medical residents. Her research interests include increasing access to kidney and pancreas transplantation and improving clinical and patient-centered outcomes of kidney transplant recipients.
Dr. Concepcion has served on several important national committees and workgroups including the United Network for Organ Sharing/Organ Procurement and Transplantation Network Kidney Committee from 2020-2023. Currently, she is a member of the American Society of Nephrology/American Society of Transplantation Taskforce created to pursue ACGME accreditation for transplant nephrology as a specialty. She is also the co-chair of the National Kidney Foundation’s Health Equity Advisory Committee and a member of the American Society of Nephrology's Public Policy and Advocacy Committee. She is a Fellow of the American Society of Nephrology and a Fellow of the American Society of Transplantation.
Hypothermic Machine Perfusion in Deceased Donor Kidney Transplantation: Provider and Transplant Center Practices and Perspectives.
Hypothermic Machine Perfusion in Deceased Donor Kidney Transplantation: Provider and Transplant Center Practices and Perspectives. Clin Transplant. 2026 Aug; 40(8):e70637.
PMID: 42573133
Skin Lesions in a Kidney Transplant Recipient: Key to an Early Diagnosis.
Skin Lesions in a Kidney Transplant Recipient: Key to an Early Diagnosis. Transpl Infect Dis. 2026 Jul-Aug; 28(4):e70258.
PMID: 42237484
A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assay to Predict Early Acute Rejection.
A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assay to Predict Early Acute Rejection. Kidney360. 2026 Aug 01; 7(8):1792-1806.
PMID: 42133442
Patients' Perceptions of Kidney Transplant Failure and Return to Dialysis.
Patients' Perceptions of Kidney Transplant Failure and Return to Dialysis. Kidney Med. 2026 Jul; 8(7):101379.
PMID: 42211686
Updates in guidelines and policy for selection, care and aftercare of the living kidney donor.
Updates in guidelines and policy for selection, care and aftercare of the living kidney donor. Curr Opin Organ Transplant. 2026 Jun 01; 31(3):149-155.
PMID: 41846389
Is the Current Practice of Out-of-Sequence Kidney Allocation Justified? Assessing Outcomes, Utility, Efficiency, and Equity.
Is the Current Practice of Out-of-Sequence Kidney Allocation Justified? Assessing Outcomes, Utility, Efficiency, and Equity. Clin J Am Soc Nephrol. 2026 Apr 01; 21(4):541-543.
PMID: 41817589
Association of Posttransplant Kidney Function With Patient Reported Outcomes: A Single Center's Experience Over Nearly Two Decades.
Association of Posttransplant Kidney Function With Patient Reported Outcomes: A Single Center's Experience Over Nearly Two Decades. Clin Transplant. 2026 Mar; 40(3):e70500.
PMID: 41770124
Prophylactic role of tixagevimab/cilgavimab for COVID-19 in newly transplanted kidney recipients: Single-center experience and review of literature.
Prophylactic role of tixagevimab/cilgavimab for COVID-19 in newly transplanted kidney recipients: Single-center experience and review of literature. World J Transplant. 2025 Dec 18; 15(4):100041.
PMID: 41357415
Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement.
Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement. Transplant Direct. 2026 Jan; 12(1):e1893.
PMID: 41415033
Passenger Lymphocyte Syndrome Presenting With Severe Refractory Thrombocytopenia After Transplantation: A Multi-Recipient Case Series.
Passenger Lymphocyte Syndrome Presenting With Severe Refractory Thrombocytopenia After Transplantation: A Multi-Recipient Case Series. Clin Transplant. 2025 Sep; 39(9):e70295.
PMID: 40966359